| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |